EUVIMEDSkopri EUVIMED
Multizentrische StudieOpen access · CC BY-NC 4.0

Research Communication: Real‐World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education

Sarah Taylor iD, Emily Barwick, Varan Perananthan iD, Nikita Parkash, Sarah Lucas iD, Ayushi Chauhan iD, Catherine Yu iD, Katrina Tan, Gloria Sepe, Mani Suleiman, Diana Lewis, Chamara Basnayake iD and 4 more

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70197 ↗

At a glance

Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2025. Written by Sarah Taylor and 15 co-authors. Institution: Department of Gastroenterology, Northern Health, Epping, Victoria, Australia. Major MEDLINE topics: Budesonide, Eosinophilic Esophagitis, Anti-Inflammatory Agents. Cited 2 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY-NC 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Budesonide orodispersible tablets (BOT) have been shown to be efficacious for eosinophilic oesophagitis (EoE) in clinical trials. This study evaluated the real‐world effectiveness of BOT in a retrospective cohort of 94 patients across six tertiary centres. 61% of patients achieved histological remission and 39% clinicohistological remission following induction therapy. Adverse events were reported by 16% of patients and 17% were noted to have incorrect technique of administration. BOT was demonstrated to have lower rates of clinicohistological remission in real‐world practice than reported in clinical trials, largely due to incorrect technique and cessation due to adverse events.

Subjects

MeSH terms (MEDLINE)

BudesonideEosinophilic EsophagitisAnti-Inflammatory AgentsHumansMaleFemaleRetrospective StudiesTreatment OutcomeAdultMiddle AgedTabletsAdministration, OralPatient Education as TopicAgedYoung AdultAdolescent

Substances

BudesonideTabletsAnti-Inflammatory Agents

Authors and institutions

  • Department of Gastroenterology, Northern Health, Epping, Victoria, Australia.
  • The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Research Development and Governance Unit, Northern Health, Epping, Victoria, Australia.
  • Research and Industry Engagement, La Trobe University, Bundoora, Victoria, Australia.

ORCID profiles: Sarah Taylor, Varan Perananthan, Sarah Lucas, Ayushi Chauhan, Catherine Yu, Chamara Basnayake, Mayur Garg

Cite

APA

Taylor, S., Barwick, E., Perananthan, V., Parkash, N., Lucas, S., Chauhan, A., Yu, C., Tan, K., Sepe, G., Suleiman, M., Lewis, D., Basnayake, C., Philpott, H., Nandurkar, S., Burgell, R., & Garg, M. (2025). Research Communication: Real‐World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70197

Vancouver

Taylor S, Barwick E, Perananthan V, Parkash N, Lucas S, Chauhan A, et al. Research Communication: Real‐World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70197

BibTeX
@article{Taylor2025,
  author = {Taylor, Sarah and Barwick, Emily and Perananthan, Varan and Parkash, Nikita and Lucas, Sarah and Chauhan, Ayushi and Yu, Catherine and Tan, Katrina and Sepe, Gloria and Suleiman, Mani and Lewis, Diana and Basnayake, Chamara and Philpott, Hamish and Nandurkar, Sanjay and Burgell, Rebecca and Garg, Mayur},
  title = {Research Communication: Real‐World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70197}
}
Start for free →